Conduction system pacing as a primary strategy for cardiac resynchronization therapy in reduced ejection fraction: An updated systematic review and meta-analysis of randomized controlled trials
Progress in Cardiovascular Diseases · 2026-08
DOI: 10.1016/j.pcad.2026.08.004 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Progress in Cardiovascular Diseases, 2026-08. Verfasst von Shunsuke Kuroda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Johnson and Johnson.
Abstract (Originalsprache)
BACKGROUND: Biventricular pacing (BVP) is the standard for cardiac resynchronization therapy (CRT), particularly in left bundle branch block (LBBB). However, conduction system pacing (CSP) may offer superior outcomes as a physiological alternative. We evaluated the clinical efficacy of CSP compared with BVP as a primary strategy for patients with heart failure indicated for CRT. METHODS: A systematic review and meta-analysis was conducted using MEDLINE and the Cochrane Library databases. We included randomized controlled trials (RCTs) comparing CSP with BVP in patients with heart failure and a left ventricular ejection fraction below 50%. Pooled estimates were determined using a random-effects model for all outcomes. RESULTS: Twelve RCTs involving 1223 patients were included. CSP significantly improved the echocardiographic response compared with BVP in the overall cohort (odds ratio [OR]: 1.73; 95% confidence interval [CI]: 1.19-2.52) and the LBBB subgroup (OR: 1.74; 95% CI: 1.15-2.62). CSP revealed significant improvements in NYHA functional class (standardized mean difference: -0.27; 95% CI: -0.46 to -0.08) and 6-min walk distance (mean difference: 21.6 m; 95% CI: 8.07 to 35.14). While composite endpoints (OR: 0.59; 95% CI: 0.33 to 1.08) and mortality (OR: 0.90; 95% CI: 0.39 to 2.11) showed trends favoring CSP, neither reached statistical significance. There was no significant difference in procedural crossovers between the groups (OR: 1.24; 95% CI: 0.54 to 2.87). CONCLUSION: Compared with BVP, CSP improved echocardiographic and functional response in patients requiring CRT. CSP as a primary strategy may be considered in selected patients, but large RCTs with hard clinical endpoints are needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
- College of Medicine, School of Medicine and Health Sciences, University of Tsukuba, Tsukuba, Japan.
- Department of Cardiovascular Medicine, Institute of Science Tokyo, Tokyo, Japan.
- Division of Cardiovascular Medicine, Section of Heart Failure and Transplantation, University of Iowa, Iowa City, IA, USA.
- Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA; Richard A and Susan F Smith Center for Outcomes Research in Cardiology, Beth Israel Deac…
Förderung
- Johnson and Johnson
Zitieren
APA
Kuroda, S., Okamura, Y., Kawamura, I., Aikawa, T., Briasoulis, A., & Kuno, T. (2026). Conduction system pacing as a primary strategy for cardiac resynchronization therapy in reduced ejection fraction: An updated systematic review and meta-analysis of randomized controlled trials. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2026.08.004
Vancouver
Kuroda S, Okamura Y, Kawamura I, Aikawa T, Briasoulis A, Kuno T. Conduction system pacing as a primary strategy for cardiac resynchronization therapy in reduced ejection fraction: An updated systematic review and meta-analysis of randomized controlled trials. Progress in Cardiovascular Diseases. 2026. doi:10.1016/j.pcad.2026.08.004
BibTeX
@article{Kuroda2026,
author = {Kuroda, Shunsuke and Okamura, Yui and Kawamura, Iwanari and Aikawa, Tadao and Briasoulis, Alexandros and Kuno, Toshiki},
title = {Conduction system pacing as a primary strategy for cardiac resynchronization therapy in reduced ejection fraction: An updated systematic review and meta-analysis of randomized controlled trials},
journal = {Progress in Cardiovascular Diseases},
year = {2026},
doi = {10.1016/j.pcad.2026.08.004}
}
EUVIMED